Allergan Declines To Confirm Abicipar Pegol Fate
Is There A Future For The Investigational Ophthalmic Treatment?
There is speculation that it is the end of the road for abicipar pegol but Allergan has declined to say whether this is the case for the product that has been in development for wet AMD.
